NL-OMON55710招募中不适用
*MRI protocol development for MR-linac* - MR-linac
niversitair Medisch Centrum Utrecht0 个研究点目标入组 900 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 900
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:, - >= 18 years
- •- Capable and prepared to sign informed consent
- •- Healthy volunteers or cancer patients who will be or are treated at the
- •radiotherapy department, or patients with cancer at a stage or at a site that
- •is not routinely treated with radiotherapy, where the aim is that future
- •patients with a similar tumor stage or tumor site might be treated on the MRL.
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:, - Contraindication for MRI scanning as
- •listed in screening form
- •- Neurological or psychiatric diagnosis
- •- MRI contraindications such as (possible) pregnancy and metal or electronic
- •implants not compatible with MRI
- •- Refusal of subjects to be informed of chance findings possibly relevant to
- •their health
- •- In case study participation would interfere with regular treatment
研究者
相似试验
已完成
不适用
Development of an MRI scanning protocol for functional imaging of esophageal cancer.oesophageal cancer1001799010017991esophageal cancerNL-OMON44018niversitair Medisch Centrum Utrecht30
尚未招募
不适用
Development of a multiparametric MRI protocol for Evaluation of morphology, ventilation and perfusion of the lung without contrast media.lung diseasecystic fibrosisJ00-J99Diseases of the respiratory systemDRKS00020802niversitätsklinikum Ulm350
已完成
不适用
MRI protocol development at clinical field strengthsGezonde vrijwilligersHealthy control subjectsNL-OMON35342eids Universitair Medisch Centrum500
已完成
不适用
First-In Man (FIM) study MR-LinacBot metastasenBone metastasescancerNL-OMON45369Elekta5
招募中
不适用
The MR-Linac Technical Feasibility Protocol For Development of MR-guided Adaptive Radiation Therapy.malignancy10027655CancerNL-OMON54848Antoni van Leeuwenhoek Ziekenhuis140